iRhythm Technologies (NASDAQ: IRTC) posted second-quarter results that beat the consensus forecast on Wall Street. The San Francisco–based company — maker of the Zio Patch for ambulatory cardiac monitoring — reported a loss of –$17.4 million, or –59¢ per share, on sales of $81.3 million for the quarter ended June 30, 2021. Revenue was up […]
Cardiovascular
Welcome to MassDevice's Cardiovascular Hub, your resource for the latest news in cardiac implants, structural heart, heart valves, stents and more. Stay informed about the innovations and business news shaping the cardiovascular device industry.
🫀 Narrow your focus with these categories:
Cardiac Implants | Structural Heart | Pulsed-Field Ablation
Here are top cardiology features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ LVADs save lives: So why aren’t more available?
+ How Medtronic uses nitinol to improve the structure and effectiveness of heart devices
+ How Abbott designed the world’s first dual-chamber leadless pacemaker system
+ J&J used RWE for expanded indications — and you can, too
+ 7 cardiology startups you need to know
Latest Cardiology News
Abiomed beats The Street in Q1, boosts full-year revenue guidance
Abiomed (NASDAQ: ABMD) posted first-quarter results that beat the consensus forecast on Wall Street, with the company boosting its revenue growth forecast to 22–24% for the fiscal year. The Danvers, Mass.–based maker of circulatory and oxygenation support devices reported a loss of –$26.5 million, or –59¢ per share, on sales of $252.5 million for the […]
AtriCure beats The Street in Q2 results
AtriCure (NSDQ:ATRC) posted second-quarter results this week that beat the overall consensus on Wall Street. The Mason, Ohio-based company reported losses of -$16.3 million, or -36¢ per share, on sales of $71.4 million for the three months ended June 30 for a sales growth of 74.84% compared with Q2 2020. Adjusted to exclude one-time items, earnings […]
Cardiovascular Systems sales up 66% in Q4
Cardiovascular Systems (NSDQ:CSII) posted fourth-quarter results that beat the overall consensus on Wall Street. The St. Paul, Minn.-based company yesterday evneing reported losses of –$5.3 million, or -14¢ per share, on sales of $70.7 million for the three months ended June 30, 2021 — versus a loss of –$15.2 million on sales of 42.5 million […]
HeartFlow appoints former Medtronic executive as COO
HeartFlow today announced that it has appointed John Farquhar as chief operating officer, effective immediately. Farquhar will be responsible for executing the strategic vision of the Redwood City, Calif.–based company — developer of the non-invasive HeartFlow FFRCT analysis. “We are thrilled to add an executive of John’s caliber and accomplishments to the HeartFlow leadership team,” […]
Boston Scientific initiates trial for EkoSonic endovascular system
Boston Scientific (NYSE:BSX) announced today that it began enrollment for a clinical trial of its EkoSonic endovascular system (EKOS). Marlborough, Mass.–based Boston Scientific’s HI-PEITHO trial, a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz, will compare EkoSonic in combination with […]
FDA approves Kestra Medical Technologies’s wearable cardioverter defibrillator
Kestra Medical Technologies announced today that it received FDA approval for its Assure wearable cardioverter defibrillator (WCD) system. Kirkland, Wash.-based Kestra designed its Assure WCD system as a modern, comfortable wearable device with integrated sensors, a cardiac rhythm monitor and a miniaturized automated external defibrillator, according to a news release. The system, designed to protect […]
How Olympus is using AI to find patients for its COPD device
Olympus recently announced its SeleCT Connect program, which uses diagnostic imaging AI to automatically screen which people might benefit from its Spiration valve system. Spiration is an FDA-designated breakthrough device for treating chronic obstructive pulmonary disease (COPD) patients. SeleCT Connect — offered as part of Olympus’ SeleCT quantitative computer tomography (QCT) analysis service — is […]
Abbott wins FDA clearance for AI-based heart vessel imaging tech
Abbott (NYSE:ABT) announced today that it received FDA clearance for its latest optical coherence tomography (OCT) imaging platform. Powered by the company’s new Ultreon software, the latest imaging platform combines OCT with artificial intelligence (AI) to provide physicians with an enhanced, comprehensive view of coronary blood flow and blockages to aid in physician decision-making, according […]
Cardinal Health completes $1B sale of Cordis business
Cardinal Health (NYSE: CAH) announced today that it has completed the sale of its Cordis business to private equity firm Hellman & Friedman. The $1 billion sales price included includes H&F’s assumption of certain liabilities and Cardinal Health’s retention of some working capital accounts. “As we shared previously, this divestiture demonstrates our disciplined portfolio evaluation […]
Abbott CMO Dr. Nick West touts latest iteration of drug-eluting stent
Abbott executive Dr. Nick West believes the company offers the “best-in-class” drug-eluting stent with its Xience platform. When Abbott (NYSE:ABT) CMO & divisional VP of global medical affairs for its vascular business Dr. Nick West looks back at his use of drug-eluting stents in the early 2000s, all he sees now is innovation. As a practicing interventional cardiologist, West […]